← Back to Search

Behavioural Intervention

Brain Stimulation for Memory Improvement in Healthy Adults

N/A
Waitlist Available
Led By Sven Vanneste, PhD
Research Sponsored by The University of Texas at Dallas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age: 18-35 years Native English Speaker
Native English Speaker
Must not have
History of heart disease
History of epileptic insults
Timeline
Screening 3 weeks
Treatment Varies
Follow Up associate memory is assessed after a 10 minutes break following the study phase

Summary

This trial is investigating whether a brain stimulator can help people learn and remember better.

Who is the study for?
This trial is for healthy adults aged 18-35 who are native English speakers. It's not suitable for those with epilepsy, heart disease, severe psychiatric or untreated medical conditions, pregnant women, people with implanted devices, or a history of severe head injuries.
What is being tested?
The study tests if learning and memory recall can be improved using transcranial Direct Current Stimulation (tDCS) during a task that involves remembering faces and names. There are three approaches: active anodal tDCS, sham (fake) tDCS, and active cathodal tDCS.
What are the potential side effects?
Possible side effects of tDCS may include mild tingling on the scalp, itching under the electrode area, a slight headache or fatigue. These side effects are generally considered to be mild and temporary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 35 years old and speak English as my first language.
Select...
I am a native English speaker.
Select...
I am between 18 and 35 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history of heart disease.
Select...
I have a history of seizures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~associate memory is assessed after a 10 minutes break following the study phase
This trial's timeline: 3 weeks for screening, Varies for treatment, and associate memory is assessed after a 10 minutes break following the study phase for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Associative Memory assessed by a Face Name Associate Memory experiment

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: active cathodal tDCSExperimental Treatment1 Intervention
active cathodal tDCS with Face Name associate Memory task
Group II: active anodal tDCSExperimental Treatment1 Intervention
active anodal tDCS with Face Name associate Memory task
Group III: Sham tDCSPlacebo Group1 Intervention
sham tDCS with Face Name associate Memory task
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
active anodal tDCS
2017
N/A
~90

Find a Location

Who is running the clinical trial?

The University of Texas at DallasLead Sponsor
64 Previous Clinical Trials
106,778 Total Patients Enrolled
7 Trials studying Healthy Adults
245 Patients Enrolled for Healthy Adults
Sven Vanneste, PhDPrincipal InvestigatorThe University of Texas at Dallas
6 Previous Clinical Trials
184 Total Patients Enrolled
1 Trials studying Healthy Adults
30 Patients Enrolled for Healthy Adults

Media Library

tDCS (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03312920 — N/A
Healthy Adults Research Study Groups: active anodal tDCS, Sham tDCS, active cathodal tDCS
Healthy Adults Clinical Trial 2023: tDCS Highlights & Side Effects. Trial Name: NCT03312920 — N/A
tDCS (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03312920 — N/A
Healthy Adults Patient Testimony for trial: Trial Name: NCT03312920 — N/A
~7 spots leftby Nov 2025